N- and K-Ras Oncogenes in Plasma Cell Dyscrasias

References

• Kyle R.A. Diagnostic criteria of multiple myeloma. Hematol. Oncol. Clin. N. Am. 1992; 6: 347–358
   PubMed Web of Science ®Google Scholar
• Knowling M.A., Haarwood A.R., Bergsagel D.E. Comparison of extramedullar plasmacytomas with solitary and multiple plasma cell tumors of the bone. J. Clin. Oncol. 1983; 1: 255–262
   PubMed Web of Science ®Google Scholar
• Barlogie B., Epstein J., Selvanayagam P., Alexanian R. Plasma cell myeloma-new biological insights and advances in therapy. Blood 1988; 73: 865–879
   Web of Science ®Google Scholar
• Ladanyi Feiner M., Niesvizky H.R., Michaeli J. Protoncogene analysis in multiple myeloma. Blood 1991; 78: 433a
   Google Scholar
• Palumbo A.P., Boccadoro M., Battaglio S., Corradini P., Tsichlis P.N., Huebner K., Pileri A., Croce C.M. Human homologous of Moloney leukemia virus integration-4 locus (MLVI-4), located 20 kilobases 3′ of the c-myc gene, is rearranged in multiple myeloma. Cancer Res. 1990; 50: 6478–6482
   PubMed Web of Science ®Google Scholar
• Selvanayagam P., Blick M., Nami F., van Tuinen P., Ledbetter D.H., Alexanian R., Saunders G.F., Barlogie B. Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma. Blood 1988; 71: 30–35
   PubMed Web of Science ®Google Scholar
• Neri A., Murphy J.P., Cro L., Ferrero D., Tarella C., Baldini L., Dalla Favera R. Ras oncogene mutation in multiple myeloma. J. Exp. Med. 1989; 170: 1715–1725
   PubMed Web of Science ®Google Scholar
• Paquette R.L., Berenson J., Lichtenstein A., McCormick F., Koeffler H.P. Oncogenes in multiple myeloma: point mutations of N-ras. Oncogene 1990; 5: 1659–1663
   PubMed Web of Science ®Google Scholar
• Corradini P., Ladetto M., Voena C., Palumbo A., Inghirami G., Knowles D.M., Boccadoro M., Pileri A. Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias. Blood 1993; 81: 2708–2713
   PubMed Web of Science ®Google Scholar
• Neri A., Baldini L., Trecca D., Cro L., Polli E., Maiolo A.T. p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood 1993; 81: 128–135
   PubMed Web of Science ®Google Scholar
• Barbacid M. Ras genes. Annu. Rev. Biochem. 1987; 56: 779–827
   PubMed Web of Science ®Google Scholar
• Gaidano G., Dalla Favera R. Protooncogenes and tumor suppressor genes. Neoplastic Hematopathology, D.M. Knowles. Williams & Wilkins, Baltimore 1992; 245–261
   Google Scholar
• Jiang W., Kahn S.M., Guillem J.G., Lu S.H., Wein-Stein I.B. Rapid detection of ras oncogenes in human tumors: Applications to colon, esophageal, and gastric cancer. Oncogene 1989; 4: 923–928
   PubMed Web of Science ®Google Scholar
• Bos J.L. Ras oncogenes in human cancer: A review. Cancer Res. 1989; 49: 4682–4689
   PubMed Web of Science ®Google Scholar
• Toksoz D., Farr C.J., Marshall C.J. Ras genes and acute leukemia. Br. J. Haematol. 1989; 71: 1–6
   PubMed Web of Science ®Google Scholar
• Ahuja H.G., Foti A., Bar-Eli M., Cline M.J. The pattern of mutational involvement of ras genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood 1990; 75: 1684–1690
   PubMed Web of Science ®Google Scholar
• Bos J.L., Verlaan-De Vries M., van der Eb J., Janssen J. W. G., Delwel R., Lowenberg B., Colly L.P. Mutations in N-Ras predominate in acute myeloid leukemia. Blood 1987; 69: 1237–1241
   PubMed Web of Science ®Google Scholar
• Neri A., Knowles D.M., Greco A., McCormick F., Dalla and Favera R. Analysis of ras oncogene mutations in human lymphoid malignancies. Proc. Natl. Acad. Sci. USA 1988; 85: 9268–9272
   PubMed Web of Science ®Google Scholar
• Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction. Genomics 1989; 5: 874–882
   PubMed Web of Science ®Google Scholar
• Portier M., Molès J.P., Mazars G.R., Jeanteur P., Ba-Taille R., Klein B., Theillet C. p53 and ras gene mutations in multiple myeloma. Oncogene 1992; 7: 2539–2543
   PubMed Web of Science ®Google Scholar
• Boccadoro M., Marmont F., Tribalto M., Fossati G., Re-Doglia V., Battaglio S., Massaia M., Gallamini A., Comotti B., Barbui T., Campobasso N., Dammacco F., Cantonetti M., Petrucci M.T., Mandelli F., Resegotti L., Pileri A. Early responder myeloma: Kinetic studies identify a patients subgroup characterized by very poor prognosis. J. Clin. Oncol. 1989; 7: 119–125
   PubMed Web of Science ®Google Scholar
• Durie B. G. M., Stock-Novack D., Salmon S.E., Finley P., Beckord J., Crowley J., Coltman C.A. Prognostic value of pretreatment serum beta-2 microglobulin in myeloma: A Southwest Oncology Group Study. Blood 1990; 75: 823–830
   PubMed Web of Science ®Google Scholar
• Bataille R., Boccadoro M., Klein B., Durie B. G. M., Pileri A. C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood 1992; 80: 733–737
   PubMed Web of Science ®Google Scholar
• Bergui L., Schena M., Gaidano G., Riva M., Cali-garis-Cappio F. Interleukin 3 and interleukin 6 syn-ergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. J. Exp. Med. 1989; 170: 613–620
   PubMed Web of Science ®Google Scholar
• Epstein J., Xiao H., He X.Y. Markers of multiple hematopoietic-cell lineages in multiple myeloma. N. Engl. J. Med. 1990; 322: 664–668
   PubMed Web of Science ®Google Scholar
• Corradini P., Boccadoro M., Voena C., Pileri A. Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C/u sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas. J. Exp. Med. 1993; 178: 1091–1096
   PubMed Web of Science ®Google Scholar
• Seremetis S., Inghirami G., Ferrero D., Newcomb E.W., Knowles D.M., Dotto G.P., Dalla Favera R. Transformation and plasmacytoid differentiation of EBV-in-fected human B lymphoblasts by ras oncogenes. Science 1989; 243: 660–663
   PubMed Web of Science ®Google Scholar
• Kumar R., Sukumar S., Barbacid M. Activation of ras oncogenes preceding the onset of neoplasia. Science 1990; 248: 1101–1104
   PubMed Web of Science ®Google Scholar
• Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759–767
   PubMed Web of Science ®Google Scholar
• Van Kamp H., De Pijper C., Verlaan-de Vries M., Bos J.L., Leeksma C. H. W., Kerkhofs H., Willemze R., Fibbe W.E., Landegent J.E. Longitudinal analysis of point mutations of the N-ras proto-oncogene in patients with myelodysplasia using archived blood smears. Blood 1992; 79: 1266–1270
   PubMed Web of Science ®Google Scholar